Cardiovascular surgeons employ myocardial revascularization as a vital therapeutic strategy for individuals grappling with coronary artery disease, a prevalent cardiovascular affliction. The primary objective of this medical intervention is to reinstate optimal blood circulation to the heart muscle, mitigating the impact of arterial blockages. Myocardial revascularization encompasses various techniques, including coronary artery bypass grafting and angioplasty, each tailored to address specific intricacies of the arterial blockages. By skillfully navigating through the complexities of the cardiovascular system, surgeons endeavor to alleviate ischemic heart conditions and ameliorate symptoms such as angina. The strategic deployment of bypass grafts or the dilation of narrowed arteries through angioplasty plays a pivotal role in restoring the heart's blood supply. This, in turn, contributes significantly to minimizing chest pain, enhancing overall cardiac function, and ultimately diminishing the likelihood of debilitating heart attacks.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States